AGÕæÈ˹ٷ½

Welltower (WELL) posted another quarter of strong top-line growth. Q2-25 total revenue jumped 40% YoY to $2.55 bn, driven by a 41% rise in resident fees/services and a 44% rise in rental income as the Care UK (closed Oct-24) and Aspire skilled-nursing assets (Feb-25) flowed into results. Net income attributable to common shareholders increased 19% to $301.9 mm; diluted EPS rose to $0.45 from $0.42. For the first six months, revenue rose 35% to $4.97 bn and EPS climbed 32% to $0.85. The quarterly dividend was lifted 10% YoY to $0.67 and represented a 74% payout of YTD EPS.

Balance sheet capacity remains solid, but spending is heavy. Total assets reached $55.8 bn (+9% YTD); cash rose to $4.41 bn after issuing $4.0 bn of common equity and $1.36 bn of notes, partly offset by $1.25 bn note redemption. Net property acquisitions/CapEx absorbed $3.65 bn, largely Seniors Housing Operating ($2.44 bn) and Triple-net ($1.12 bn). Debt stood at $15.97 bn (3.9% blended unsecured rate) with no revolver or CP outstanding. YTD operating cash flow grew 35% to $1.37 bn, covering dividends 1.6×.

Strategic activity accelerates growth. Key moves include: 1) 48-facility Aspire acquisition ($991 mm), 2) completion of Chartwell JV unwinding (gain $53 mm), 3) launch of a private seniors-housing fund ($279 mm GP stake), and 4) a C$4.6 bn agreement to buy Amica (closing late 25/early 26). Impairments of $72 mm, higher depreciation and rising interest expense temper bottom-line expansion, but underlying NOI momentum (top-5 operators now 28% of NOI) and liquidity position WELL to continue acquisitive growth.

RLI Corp. (Q2 2025 Form 10-Q) delivered a strong quarter.

• Revenue: $499.8 m, +20% YoY driven by 6% higher net premiums earned ($401.9 m) and a 16% rise in investment income.
• Underwriting & investment gains: Net realized gains swung to +$15.0 m (vs. â€�$0.2 m); equity portfolio added $43.5 m of unrealized gains.
• Profitability: Net earnings jumped 52% to $124.3 m; diluted EPS $1.34 vs. $0.89. Combined expense items grew 10%, slower than revenue growth, expanding pre-tax margin to 31% (vs. 25%).
• Six-month view: Premiums up 8% to $800.3 m but YTD net earnings fell 11% to $187.6 m, reflecting softer Q1 results. Diluted EPS $2.03 vs. $2.27.
• Balance sheet: Assets $5.99 bn (+6% YTD); shareholdersâ€� equity $1.73 bn (+14%) aided by AOCI improvement (-$125 m vs. -$174 m). Book value benefited from falling rates.
• Cash flow: Operating cash flow rose 31% to $278.2 m; cash ended at $21.4 m after sizable securities purchases.
• Capital actions: Two-for-one stock split effected 15 Jan 2025; quarterly dividend raised to $0.16/share.

Union Pacific Corp. (UNP) â€� Form 4 insider transaction

EVP Marketing & Sales Kenyatta G. Rocker reported two small open-market acquisitions on 10 July 2025 that were executed through the company’s 2021 Employee Stock Purchase Plan:

• 12.87 UNP common shares purchased directly at an indicated price of $237 per share.
• 3.025 UNP common shares purchased indirectly by the reporting person’s spouse at the same price.

Following these transactions, the executive’s beneficial ownership totals:

• Direct: 52,224.9767 shares
• Indirect â€� Spouse: 1,265.8917 shares
• Indirect â€� Deferral Account: 350 shares
• Indirect â€� Managed Account: 2,031.7113 shares

No derivative security activity or dispositions were disclosed. The filing is administrative in nature and does not indicate any change in strategy or outlook by Union Pacific.

Immunovant, Inc. (IMVT) â€� Form 4 filed 07/11/2025

Chief Technology Officer Jay S. Stout disclosed a routine, non-discretionary insider transaction tied to restricted stock unit (RSU) vesting.

• Shares sold: 1,519 common shares on 07/09/2025
• Weighted-average price: $17.24 (price range $17.00â€�$17.50)
• Reason: Automatic “sell-to-coverâ€� to satisfy tax withholding on the vesting of 3,436 RSUs granted 04/02/2024 (first tranche vested 07/02/2025)
• Ownership after sale: 207,724 shares held directly

The filing notes that the sale was mandated by company policy and therefore does not reflect an elective liquidation by the executive. Given the modest size relative to the remaining stake and the absence of other material disclosures, the event is considered routine with limited market impact.

Form 4 filing overview: Union Pacific Corp. (UNP) reports that EVP & Chief Information Officer Rahul Jalali purchased 9.569 shares of the company’s common stock on 07/10/2025 at a price of $237 per share under the company’s 2021 Employee Stock Purchase Plan (ESPP). Following the transaction, Jalali’s direct ownership stands at 28,787.115 shares. No derivative securities were involved, and there were no dispositions.

The filing reflects a routine, low-dollar ESPP acquisition that marginally increases insider ownership but does not represent a material change in the company’s share structure or insider sentiment.

Insmed, Inc. (INSM) � Form 144 notice of proposed sale

The filing discloses that Michael A. Smith intends to sell 748 shares of Insmed common stock through Merrill Lynch on or about 11 July 2025. The shares carry an aggregate market value of $72,114, implying a reference price of roughly $96 per share. Insmed has 182,138,923 shares outstanding, so the planned sale represents only 0.0004 % of the float.

The form also lists insider transactions over the preceding three months: Smith sold 34,470 shares between 14 May 2025 and 5 June 2025 for gross proceeds of $2.4 million. Even these cumulative sales equal just 0.019 % of shares outstanding. All sales were made under Rule 144, which governs the resale of restricted or control securities.

No financing, earnings, or operational data accompany the filing; the document’s sole purpose is to give advance notice of this modest insider disposition and to certify that the seller is unaware of undisclosed material adverse information.

Union Pacific Corp. (UNP) Executive Vice President â€� Operations Eric J. Gehringer filed a Form 4 reporting a modest insider purchase on 10 July 2025. Through the company’s 2021 Employee Stock Purchase Plan he acquired 3.797 shares of UNP common stock at $237 each. After the transaction, Gehringer directly owns 44,538.9836 shares and indirectly holds 7,179.393 shares in a deferral account; no new derivative positions were created or exercised. The incremental buy is immaterial relative to his existing stake and Union Pacific’s market capitalization, so the filing adds limited fundamental insight, but insider purchases are generally viewed as a signal of executive confidence.